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ABSTRACT OF THE DISSERTATION
Screening Adherence and Emotional Adjustment of
Daughters of Breast Cancer Patients
by
Sarah R. Ormseth
Doctor of Philosophy, Graduate Program in Clinical Psychology
Loma Linda University, September 2013
Dr. Adam Aréchiga, Chairperson

Women at high risk for breast cancer oftentimes also experience psychological
vulnerably related to experiences of cancer in their family, high bereavement rates and
their own uncertainties regarding if and when they may develop the disease. This
research sought to evaluate psychological adjustment and examine reattendance among a
sample of women adhering to regular breast cancer surveillance, with a specific focus on
daughters of breast cancer patients. The study described in Chapter 2 longitudinally
profiled anxiety and depressive symptoms among these high-risk daughters across three
consecutive surveillance appointments, and also evaluated the effects of a set of
hypothesized predictors on change in symptomatology. The results showed an overall
decrease in anxiety over the course of the three surveillance visits, as well as a marginally
significant decrease in depressive symptoms. When the effects of moderating variables
on symptom change were examined, results demonstrated that some subgroups of
daughters differentially benefited from the high-risk program, with daughters whose
mothers died who were older at the time of their mother’s diagnosis being the only group
that did not appear to experience decreases in symptomatology. The study presented in
Chapter 3 investigated psychosocial correlates of reattendance at the high-risk clinic,
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again focusing on daughters of breast cancer patients. Results showed that greater
likelihood of reattendance was associated with hypothesized predictors, including older
age, lower depressive symptoms and maternal loss to breast cancer. Moreover, mother’s
survival status was found to moderate the effect of perceived risk on likelihood of
reattendance such that higher perceived risk predicted increased reattendance for
daughters whose mothers survived, but not those whose mothers died. Additionally,
results indicated that the association between anxiety and likelihood of reattendance was
non-linear in nature (inverted “U”); reattendance was more likely among daughters with
moderate anxiety compared to those with low or high anxiety. Findings from these
studies contribute to a greater understanding of psychological adjustment and screening
adherence of women at high-risk for breast cancer and may inform the development of
targeted interventions to promote screening adherence and psychosocial wellbeing among
this and other vulnerable high-risk populations.
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CHAPTER ONE
INTRODUCTION

Despite recent progress in early detection and treatment, breast cancer remains a
serious health concern. Excluding skin cancer, breast cancer is the most frequently
diagnosed cancer in women and ranks second as a cause of cancer death, with 234,580
new cases and 40,030 breast cancer deaths expected in 2013 in the United States (Siegel,
Naishadham, & Jemal, 2013). Family history of breast cancer is a significant risk factor
for development of the disease, particularly for women with first-degree relatives
diagnosed with breast cancer (Calle, Martin, Thun, Miracle, & Heath, 1993; Sattin et al.,
1985; Sellers et al., 1999; Slattery & Kerber, 1993). A woman’s breast cancer risk
approximately doubles if a first-degree relative, such as a mother, has been diagnosed.
Women with a family history of breast cancer are at higher risk for breast cancer than the
general population because of shared genetic factors and possibly because of shared
exposures to environmental and lifestyle risk factors (Easton, 2002; Slattery & Kerber,
1993).
A number of general and cancer-related psychosocial difficulties may also be
associated with high-risk status. Many women at high risk for breast cancer experience
elevated levels of general anxiety (Lindberg & Wellisch, 2001) and report levels of
distress significant enough to warrant psychological counseling (Kash, Holland, Osborne,
& Miller, 1995), which can negatively affect quality of life. Furthermore, research has
shown that high-risk women overestimate their risk of developing breast cancer
(Katapodi, Lee, Facione, & Dodd, 2004), experience higher levels of anxiety related to
cancer screening (Lindberg & Wellisch, 2001), express greater concern about breast
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cancer, and endorse less confidence in available treatment methods for the illness
(Cappelli et al., 2005; Wellisch et al., 1999). Psychosocial distress among women at high
risk for breast cancer warrants concern given its influence on quality of life, as well as its
negative impact on cancer screening adherence (Hay, McCaul, & Magnan, 2006).
Screening for breast cancer in high-risk women may include mammography,
clinical breast examination, breast self-examination, and more recently, magnetic
resonance imaging. While research is mixed regarding which of the various screening
methods and technologies is most effective, some form of regular screening is necessary
to permit early breast cancer detection in women at higher familial risk of breast cancer.
While regular screening for high risk women is important, the importance of the setting
in which screening occurs is also receiving increasing recognition. The need for
centralized multidisciplinary care of women at high risk for breast cancer has resulted in
recommendations for, and the development of, such clinics (Kuschel, Lux, Goecke, &
Beckmann, 2000). This stems from recognition of some problems that may be associated
with ongoing cancer surveillance through individual private specialists in a nonmultidisciplinary context (Antill, Shanahan, & Phillips, 2005). For example, it may be
inconvenient for a woman to attend multiple specialists and diagnostic facilities on
different days and in different locations. A decentralized arrangement may also hinder
coordination of care. Additionally, it may be difficult for some women to independently
locate breast specialists with particular expertise in high-risk populations.
The UCLA Revlon Breast Center High Risk Clinic is a multidisciplinary center
that setting that serves patients at familial risk for breast cancer. Patients are seen once or
twice a year for a personalized surveillance program, based on individual risk factors. A
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multidisciplinary team manages patient care, including a nurse practitioner to perform a
breast exam, teach breast self-examination, and order same day diagnostic tests such as a
mammogram, ultrasound or MRI as needed. A medical oncologist will offer counsel
about breast cancer risks risk reduction strategies. A Genetic counselor will also provide
education and counseling.
Additionally, patients are seen by specialists whose services may be more difficult
to obtain outside the context of a multidisciplinary clinic. A physician nutritionist, who
specializes in cancer risk, makes recommendations for modifying diet. This is important
because research is increasingly showing the association between diet and lifestyle and
risk for developing breast cancer. Significantly, patients are also seen by a psychologist
to discuss the feelings associated with being at high risk, and about coping with illness
and loss of family members to breast cancer. Psychologists and other mental health
professionals are uniquely qualified to help address many potential barriers to care among
high-risk women.
Drawing on data from the UCLA-Revlon High Risk Program, two papers were
conceptualized and written focusing on important yet understudied aspects of
psychological adjustment and healthcare utilization among women at high risk for breast
cancer, namely daughters of breast cancer patients. In a longitudinal study of the
psychological adjustment of these women across consecutive high risk clinic
appointments, the first study (Chapter 2) sought to determine the pattern of anxiety and
depressive symptoms of these daughters across the clinic visits, particularly decreases (or
increases) in symptom severity which may be reflective of positive (or negative)
outcomes related to adhering to regular surveillance appointments. In a second study
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(Chapter 3), predictors of reattendance to the high risk clinic were explored in an effort to
profile patients who may be at greater risk for not returning for follow-up appointments
for continued surveillance given their high risk status.
To the best of our knowledge, no other studies have examined predictors of
reattendance to a high-risk clinic, or long term psychological adjustment of women at
high risk for breast cancer across multiple surveillance appointments. The utility of
focusing on and striving to better understand issues of relevance to daughters of breast
cancer patients is evident in its potential to enhance the health, wellbeing and quality of
life in this population, women with a family history of breast cancer, and individuals who
are at increased hereditary risk for other cancers and diseases.
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CHAPTER TWO
EVOLUTION OF EMOTIONAL SYMPTOMS OF DAUGHTERS
OF BREAST CANCER PATIENTS

Sarah Ormseth, M.A., David Wellisch, Ph.D., Adam Aréchiga, Psy.D., DrPH

Abstract
This study longitudinally profiled anxiety and depressive symptoms of daughters
of breast cancer patients, and examined mother’s survival status, daughter age at time of
mother’s diagnosis, and style of family communication about breast cancer as moderators
of change in symptomatology across participants’ first three appointments at the UCLA
Revlon Breast Center High Risk Clinic. To evaluate the effects of hypothesized
predictors on change in anxiety and depressive symptoms, 3 (symptomatology at first,
second, and third clinic visits) × 2 (mother survived or died) × 2 (< 20 years or ≥ 20 years
old at diagnosis) × 2 (open or closed family communication) repeated measures
ANOVAs were employed. Results showed a main effect for time on state anxiety,
demonstrating a significant reduction in anxiety across clinic visits overall (p < .001).
There were also significant 3-way interactions. For state anxiety, mother’s survival status
moderated the Time × Age at Diagnosis and Time × Family Communication interaction
effects. For daughters whose mothers died, decreased anxiety was observed in those who
were younger at the time of diagnosis (p = .001). For daughters whose mothers survived,
anxiety was decreased for those with closed family communication styles (p = .001). The
Time × Mother’s Survival × Age at Diagnosis interaction was also significant for
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depressive symptoms (p = .001). Among daughters whose mothers died, those who were
younger showed decreases in symptoms (p = .004). Overall, these daughters appeared to
benefit from the high-risk program as demonstrated by decreased symptomatology,
particularly daughters whose mothers died who were younger at the time of diagnosis.
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Introduction
In addition to the psychological distress often experienced by children of cancer
patients (Visser, Huizinga, van der Graaf, Hoekstra, & Hoekstra-Weebers, 2004; Watson
et al., 2005), daughters whose mothers are diagnosed with breast cancer must also cope
with learning of their own heightened susceptibility to the disease (Facione, 2002; Raveis
& Pretter, 2005). These daughters and other women with a strong family history of breast
cancer face ambiguity and threat about if and when cancer will develop, as well as
decisions about how to manage this increased risk. Risk-reducing surgery and
chemoprevention significantly reduce breast cancer risk, but uptake of these strategies is
low (Schwartz et al., 2012). Screening and surveillance remain the mainstay of
management for most women at increased breast cancer risk (Field & Phillips, 2007).
Because women at high risk for breast cancer experience greater levels of general and
cancer-specific distress (Baider, Ever-Hadani, & Kaplan De-Nour, 1999; Bovbjerg &
Valdimarsdottir, 2001; Gilbar, 1998; Zakowski et al., 1997), some concern exists about
the potential psychological burden of long term breast cancer surveillance.
Increased distress is common for many high-risk women the day of screening
appointments (Valdimarsdottir et al., 1995; Zakowski et al., 1997). In general though,
research has not evidenced lasting adverse psychological outcomes related to breast
cancer screening among high-risk women (Brédart et al., 2012; Rijnsburger et al., 2004;
Watson, Henderson, Brett, Bankhead, & Austoker, 2005). Findings from a large,
prospective cohort study of women with a family history of breast cancer showed
significant decreases in distress six months after mammography (Brain et al., 2008;
Tyndel et al., 2007). Although research of the effects of adhering to a breast cancer
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surveillance program is more limited, findings from the Dutch magnetic resonance
imaging screening (MRISC) study of women at increased breast cancer risk have
demonstrated short term reductions in distress following two successive screening
appointments (van Dooren et al., 2005), as well as long term reductions in intrusion and
avoidance (den Heijer et al., 2013).
While most women with a family history do not appear to experience significant
distress associated with breast cancer surveillance, some are more prone to persistent
adjustment difficulties and may benefit from additional psychosocial support. Research
suggests that several demographic, clinical and psychological factors may influence
adjustment to breast cancer surveillance (den Heijer et al., 2013; Gopie, Vasen, &
Tibben, 2012; van Dooren et al., 2005). Mother’s breast cancer diagnosis and/or death
from breast cancer are well-established risk factors for maladaptation among high-risk
women (Erblich, Bovbjerg, & Valdimarsdottir, 2000; Thewes, Meiser, Tucker, &
Schnieden, 2003; Wellisch, Gritz, Schain, Wang, & Siau, 1991; Wellisch, Ormseth,
Hartoonian, & Owen, 2012). In studies of psychological adjustment in the context of
breast cancer screening, death of a close relative to breast cancer has been found to be
associated with increased levels of cancer-specific distress (Brain et al., 2008; den Heijer
et al., 2013). Given the unique psychosocial burden faced by daughters whose mothers
have been diagnosed with breast cancer (Raveis & Pretter, 2005; Thewes et al., 2003), it
seems important for research to further examine the specific impact of maternal loss to
breast cancer on emotional response to surveillance.
For women with a family history of breast cancer, other aspects of their
experiences of breast cancer in their family may moderate the psychological effects of
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surveillance. The salience of specific risk factors varies according to the developmental
phase of a woman at the time of the diagnosis of a parent and/or loss of a first degree
relative. Studies of daughters of breast cancer patients have shown greater adjustment
difficulties among women who were younger at the time mother’s diagnosis (van
Oostrom et al., 2006; Wellisch, Gritz, Schain, Wang, & Siau, 1992), and whose mothers
died of breast cancer at a younger age (Erblich et al., 2000; Esplen & Hunter, 2002).
Previous research has also shown that that open family communication regarding breast
cancer has a positive effect on general and breast cancer specific distress (den Heijer et
al., 2011), as well as short- and long-term adjustment to genetic testing (van Oostrom et
al., 2007; van Oostrom et al., 2003). To our knowledge however, no previous study has
investigated the impact of factors related to women’s experiences of breast cancer in their
family on adjustment to breast cancer surveillance among daughters whose mothers have
been diagnosed with breast cancer.
The main aim of this study was to longitudinally profile the course of depression
and anxiety symptoms of daughters of breast cancer patients across three consecutive
biannual surveillance appointments at a high risk breast cancer clinic. It also was the
intent of this study to examine potential moderators of change in symptomatology over
time. To accomplish these goals, four hypotheses are proposed. We expected that a
higher level of depressive symptomatology would be observed among daughters whose
mothers died from breast cancer at baseline. Second, it was anticipated that a significant
reduction in anxiety symptoms, but not depressive symptomatology, would be observed
over the span of the clinic visits. Third, it was hypothesized that daughter’s age at the
time of her mother’s breast cancer diagnosis would relate to the pattern of change in
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symptoms across clinic visits such that a greater decrease in anxiety and depressive
symptomatology would be observed among daughters who were older at the time of their
mother’s diagnosis. Fourth, we expected that style of family communication about breast
cancer would be related to the pattern of change in symptoms across clinic visits such
that an open style of communication would be associated with a greater decrease in in
anxiety and depressive symptomatology. The potential interactive effects of mother’s
survival status, age at time of mother’s diagnosis and style of family communication
about breast cancer were explored, though no specific hypotheses were proposed.

Method
Institutional Review Board approval was granted prior to data collection. Study
data were obtained during participants’ first three visits to the UCLA Revlon Breast
Center High Risk Clinic. The High Risk Clinic is a multidisciplinary setting that serves
patients at familial risk for breast cancer. Patients are individually seen and counseled by
an oncologist, a genetics counselor, a nurse practitioner, a nutritionist, and a psychologist.
Women were eligible for participation if their biological mother had been diagnosed with
breast cancer, were at least 18 years old, were English-speaking, and had never
themselves been diagnosed with breast cancer. Following informed consent, participants
completed baseline questionnaires assessing depression and anxiety symptoms and a
semi-structured clinical interview in which psychosocial background information was
obtained. The depression and anxiety symptoms questionnaires were also administered to
participants at subsequent follow-up appointments. Data for 73 patients from the High
Risk Clinic from were available for analyses for the current study.
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Measures
Information was obtained regarding the survival status of the participants’
mothers (survived or passed away from breast cancer), developmental stage at the time of
their mother’s breast cancer diagnosis (less than 20 years old and 20 years of age and
older), and whether participants felt they could talk openly about their mothers’ breast
cancer with their families (open or closed communication).
The State Anxiety subscale of the State-Trait Anxiety Inventory (STAI;
(Spielberger, Gorsuch, & Lushene, 1970) was used to evaluate anxiety experienced at the
time of assessment (“state anxiety”). The State Anxiety subscale contains 20 items and
responses are measured on a 4-point Likert scale, with higher scores signifying the
presence of higher levels of anxiety. The STAI manual reports high internal consistency
for the State subscale (α = .92). For the current study, Cronbach’s alpha ranged from .86
to .92 for the three time points.
The Center for Epidemiologic Studies Depression Scale (CES-D;(Radloff, 1977)
was used to assess current depressive symptomatology. It has 20 items that measure the
frequency and intensity of depressive symptoms during the past week. Scores may range
from of 0 to 60, with higher scores signifying the presence of more symptomatology. The
test has adequate internal consistency (α = .85 for general population; α = .90 for clinical
population); the Cronbach's alpha in this study varied from .89 to .93.
Additionally, a number of variables were considered as potential covariates
including age in years at interview, ethnicity (Caucasian or non-Caucasian), marital status
(unmarried or married), educational attainment (high school, some college, college
graduate, or graduate school), employment status (currently employed or unemployed),
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number of years since mother’s diagnosis, number of relatives with a past or present
breast cancer diagnosis, and objective breast cancer risk based on the Gail model (Gail et
al., 1989).

Statistical Analyses
Repeated-measures analysis of variance (ANOVA) was used to assess the effects
of survival status of the mother and a group of selected predictors on changes in anxiety
and depressive symptomatology across participants’ first, second and third appointments
at the high risk clinic. A number of potential covariates were considered, and any shown
to be significantly associated with either of the outcome variables would have been
included the multivariate models. Two 3 × 2 × 2 × 2 repeated measures ANOVAs were
conducted with time (first, second and third clinic appointments) as the within subjects
variable, mother’s survival status (survived or died from breast cancer), participant’s age
at the time of her mother’s breast cancer diagnosis (< 20 years or ≥ 20 years old), and
style of family communication about breast cancer (open or closed family
communication style) as between subjects factors, and state anxiety (STAI State Anxiety
subtest percentile) and depressive symptomatology (CES-D score) as the dependent
variables. The assumption of sphericity was evaluated using Mauchly’s test and, if
violated, degrees of freedom were corrected using the Greenhouse-Geisser correction
factor. A full-factorial design was employed, therefore each model included main effects
as well as all two, three and four-way interactions. Significant interaction effects were
decomposed using simple effects post hoc analyses.
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Results
A total of 73 participants were included in the study. Table 1 shows background
characteristics of the sample. The sample was balanced between women whose mothers
died from breast cancer and those whose mother survived (n = 34 and n = 39,
respectively). The majority of participants were Caucasian (83.56%, n = 61) and married
(67.12%, n = 49), with an average age of 41.14 years. Additionally, the sample was
largely employed (75.34%, n = 55) and had a college or advanced degree (76.71%, n =
56). Participants exhibited absolute breast cancer risks moderately higher than that in the
general population (18.72% mean calculated lifetime risk), and the average time since the
mother’s breast cancer diagnosis was 16.44 years. With regard to the assessment of
potential covariates, none were used as control variables in the multivariate models given
their lack of association with either outcome variable. Moreover, significant differences
in baseline CES-D scores were not observed between daughters whose mothers died from
breast cancer (M = 11.40, SE = 1.84) and those whose mothers survived (M =13.64, SE =
2.04), t(71) = 0.80, p = .425.
An overall main effect for time on state anxiety was observed, F(1.69, 109.94) =
12.45, p < .001. Specifically, participants showed significantly less anxiety at the first
follow-up (M = 53.42, SE = 3.83) and second follow-up (M = 51.50, SE = 3.91) as
compared to the initial visit (M = 65.88, SE = 2.94), ps < .001. Moreover, there was a
significant three-way interaction between time, mother’s survival and age at diagnosis,
F(1.69, 109.94) = 3.77, p = .033 (see Figure 1). To facilitate interpretation of this
significant interaction, the association between time and age at diagnosis was examined
separately among daughters whose mothers died and daughters whose mothers survived.
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Table 1
Summary statistics for sample and model variables (N = 73)
Variable

Mean ± SD or N (%)

Sample characteristics
Age in years
Ethnicity
Caucasian
Non-Caucasian
Education
High school
Some college
College graduate
Graduate school
Married
Employed
Years since mother’s diagnosis
Computed risk of breast cancer
Personal estimate breast cancer risk
Number of family with breast cancer

41.14 ± 9.33

Range
20–66

61 (83.56)
12 (16.44)
5 (6.85)
12 (16.43)
28 (38.36)
28 (38.36)
49 (67.12)
55 (75.34)
16.44 ± 10.80
18.72 ± 8.22
56.29 ± 26.30
2.19 ± 1.22

Model variables
Mother’s survival status
Survived
Died from breast cancer
Age at mother’s diagnosis
Younger (< 20 years old)
Older (> 20 years old)
Family communication about breast cancer
Open communication style
Closed communication style
State anxiety percentile
Initial appointment
First return visit
Second return visit
CES-D score (depressive symptoms)
Initial appointment
First return visit
Second return visit

14

0–44.00
6.80–57.40
0–100
1–7

39 (53.42)
34 (46.58)
30 (41.10)
43 (58.90)
33 (45.21)
40 (54.79)
65.29 ± 24.10
52.81 ± 30.85
52.43 ± 30.56

10–100
2–100
2–100

12.60 ± 11.83
10.12 ± 11.61
9.97 ± 10.08

0–52
0–51
0–44

Table 2
F values for repeated measures analyses of variance models
df

State Anxiety
Percentile
F
p

df

Depressive
Symptoms
F
p

2, 130

2.63 .076

Main effects
Time (A)

1.69, 109.94 12.45 <.001

Mother survival (B)

1, 65

0.17

.686

1, 65

0.13 .718

Age at mother’s diagnosis (C)

1, 65

3.26

.076

1, 65

0.05 .829

Family communication about BC (D) 1, 65

0.50

.484

1, 65

2.16 .147

A×B

1.69, 109.94 0.19

.793

2, 130

1.80 .170

A×C

1.69, 109.94 1.82

.173

2, 130

1.61 .204

A×D

1.69, 109.94 2.77

.076

2, 130

0.33 .721

Two-way interactions

B×C

1, 65

0.75

.388

1, 65

1.44 .235

B×D
C×D

1, 65
1, 65

0.46
0.19

.500
.663

1, 65
1, 65

5.77 .019
1.94 .168

A×B×C
A×B×D

1.69, 109.94 3.77
1.69, 109.94 4.10

.033
.025

2, 130
2, 130

6.91 .001
1.42 .245

A×C×D
B×C×D

1.69, 109.94 0.98
1, 65
0.24

.366
.624

2, 130
1, 65

1.88 .157
0.39 .535

1.69, 109.94 0.05

.927

2, 130

0.50 .606

Three-way interactions

Four-way interaction
A×B×C×D

The interaction effect stems from a significant Time × Age at Diagnosis interaction
among participants whose mothers died from breast cancer, F(1.43, 43.01) = 5.15, p
=.018. Participants whose mothers died who were younger at the time of diagnosis
demonstrated a significant decrease in anxiety, F(1.24, 18.67) = 11.77, p = .001 (see
Figure 1a), namely from the first visit (M = 64.89, SE = 4.39) to the second visit (M =
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Figure 1. Means plot of change in state anxiety percentile across time based on age at
mother’s diagnosis.

39.99, SE = 6.04, p = .001) as well as from the first visit to the third visit (M = 44.84, SE
= 6.81, p = .005). For participants whose mothers survived, only the main effect of time
emerged as significant, F(2, 70) = 6.87, p = .002, with significant decreases in anxiety
from the first visit (M = 66.22, SE = 3.33) to the second visit (M = 52.04, SE = 4.97), p =
.005, and from the first visit to the third visit (M = 49.93, SE = 4.88), p = .001.
There was also a significant three-way interaction between time, mother’s
survival and style of family communication about breast cancer, F(1.69, 109.94) = 4.10,
p = .025 (see Figure 2). Further analyses revealed that the interaction effect was only
present only among participants whose mothers survived breast cancer, F(2, 70) = 6.10, p
= .004 (see Figure 2b). Follow-up contrasts showed a significant change in anxiety over
time among participants whose mothers survived who reported a closed style of family
communication, F(2, 28) = 9.30, p = .001, with decreases in symptomatology from the
first visit (M = 78.86, SE = 4.37) to the second visit (M = 54.31, SE = 9.25, p = .012),

16

Figure 2. Means plot of change in state anxiety percentile across time based on style of
family communication about breast cancer.

and from the first visit to the third visit (M = 46.69, SE = 9.24, p = .001). In contrast, style
of family communication did not moderate change in anxiety among participants whose
mothers died, F(1.43, 43.01) = 0.09, p = .855 (see Figure 2a).
With regard to depressive symptoms, there was a marginally significant overall
main effect for time on change in symptomatology, F(2, 130) = 2.63, p = .076, with a
significant decrease in depressive symptoms from the initial clinic visit (M = 12.85, SE =
1.46) to the third visit (M = 10.40, SE = 1.24), p = .032. There was also a significant
three-way interaction between time, mother’s survival and age at diagnosis, F(2, 130) =
6.91, p = .001 (see Figure 3). To facilitate interpretation of this interaction effect, the
association between time and age at diagnosis was examined separately among daughters
whose mothers died from breast cancer and daughters whose mothers survived. Followup analyses indicated a significant Time × Age at Diagnosis interaction among
participants whose mothers died, F(2, 60) = 8.26, p = .001. The effect was significant
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Figure 3. Means plot of change in depressive symptoms across time based on age at
mother’s diagnosis.

among participants whose mothers died who were younger at the time of diagnosis, F(2,
34) = 6.63, p = .004 (see Figure 3a). Specifically, there were significant decreases in
depressive symptoms from the first visit (M = 12.90, SE = 2.76) to the second visit (M =
7.55, SE = 2.28, p = .015) as well as from the first visit to the third visit (M = 7.43, SE =
1.82, p = .004). For participants whose mothers survived, only the main effect of time
emerged as significant, F(2, 70) = 3.58, p = .033, with a significant decrease in
depressive symptoms from the first visit (M = 14.31, SE = 2.18) to the third visit (M =
9.76, SE = 1.77), p = .014. With regard to the effect of style of family communication on
depressive symptoms, no main or interaction effects were shown.
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Mean State Anxiety Percentile Across High Risk Clinic Visits as a Function of Mother’s Survival Status, Age at Mother’s Breast
Cancer Diagnosis, and Style of Family Communication About Breast Cancer

Table 3
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Mean CES-D Score Across High Risk Clinic Visits as a Function of Mother’s Survival Status, Age at Mother’s Breast Cancer
Diagnosis, and Style of Family Communication About Breast Cancer

Table 4

Discussion
This study was an attempt to longitudinally profile anxiety and depressive
symptoms of daughters of breast cancer patients attending a high-risk breast cancer
clinic. A number of specific effects emerged that lend further understanding to the
influence of mother’s survival, daughter’s age at time of mother’s diagnosis, and style of
family communication about breast cancer and their relationship to the long-term
emotional functioning of these high-risk daughters. While results confirmed some
significant main effects, the interaction effects were more significantly and consistently
associated with changes in anxiety and depressive symptomatology. Overall, the findings
underscore the importance of moderating variables in understanding the long-term
adjustment of women with a family history of breast cancer adhering to a high-risk
surveillance program.
In regard to the first hypothesis, it was not the case that depressive
symptomatology was higher at baseline, or for that matter at follow-up, among women
whose mothers died from breast cancer. This finding may appear to fly in the face of
“reasonable” clinical expectations. It seems reasonable to expect that women whose
mothers died from breast cancer will enter the clinic with significantly higher levels of
depressive symptomatology. That the baseline CES-D scores were essentially identical
for daughters whose mothers died and daughters whose mothers survived suggests that
the depressing and emotionally impactful aspect of the experience involves witnessing
the mother going through the disease process. Maternal loss, therefore, is not necessarily
the only depressing stressor in this experience.
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The second hypothesis was supported in that a significant reduction in anxiety,
but not depressive symptoms, was observed over the span of the three clinic visits. This
was not unanticipated by the investigators. Anxiety is an emotional state which we are
used to seeing dramatically changed over a brief period of time in the clinic. These
daughters oftentimes enter the clinic with significant anxiety related to concerns about
their own vulnerability to breast cancer and memories of their mother’s experience with
the disease. It appears however that emotional support for women to process these issues
facilitates a rapid and significant reduction in symptoms of anxiety. This would reinforce
the notion elsewhere in the literature of the potential of single-session interventions to
affect significant changes in emotional states (Hymmen, Stalker, & Cait, 2013).
The third hypothesis was not confirmed as age at time of mother’s diagnosis, by
itself as a predictor, was not associated with change in anxiety or depressive
symptomatology. Significant effects were observed when age at the time of diagnosis
was considered in terms of the moderating effects of mother’s survival status. For
daughters whose mothers survived, the main effect for time was significant as reflected
by decreased anxiety and depressive symptomatology. The interaction between time and
age at mother’s diagnosis was significant among daughters whose mothers died from
breast cancer. In particular, and contrary to our expectations, a pronounced reduction in
anxiety symptoms was observed from the first to second clinic visits among daughters
whose mothers died who were younger at the time of diagnosis. It appears that the
opportunity to talk openly in the clinic context was less beneficial in reduction of anxiety
symptoms for daughters whose mothers died who were older at the time of diagnosis.
Research has shown that women who were older at the time of their mother’s diagnosis
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and death experience greater role strain and caretaking responsibilities (Wellisch et al.,
1991), while women who were younger during this experience were more protected
(Compas et al., 1994; Wellisch et al., 1992). Perhaps the women who were older require
more intensive and supportive interventions beyond what might be possible in the context
of the clinic visits.
In regard to hypothesis 4, by itself as a predictor, style of family communication
was not found to be associated with change in anxiety or depressive symptomatology
across clinic visits. It was only when style of family communication was considered in
interaction with mother’s survival status that it proved decisive in the data. Specifically,
the results demonstrated that daughters whose mothers survived but whose families had a
closed style of communication about breast cancer entered the clinic with significantly
elevated levels of anxiety compared to daughters whose mothers survived with an open
style of family communication and daughters with mothers who died regardless of family
communication style. This suggests that hampered family communication about breast
cancer, in the face of the continued presence of the mother in the household, may be
reflective of a particularly dysfunctional dynamic. While it is fortunate that this group of
daughters appears to derive significant benefit from the opportunity to talk about their
experiences in their first clinic visit, this finding reminds us to more carefully consider
the emotional experience of the daughter whose mother survived breast cancer. As
previously discussed, adaptive versus less adaptive adjustment and functioning on the
part of high-risk women should not be inferred solely on the basis of maternal survival
versus maternal death from breast cancer (Wellisch et al., 2012).
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The findings of this study should be considered in light of some limitations. The
sample was comprised of women adhering to regular breast cancer surveillance and may
not be generalizable to high-risk women in the community or those with limited access to
healthcare. Additionally, the sample was predominantly Caucasian, well-educated urban
women. Larger studies with more demographically representative samples would add
clarity regarding the robustness of these results. Additional research to expand on the
results of this study will further enable healthcare professionals to identify and offer
additional support to high-risk women most vulnerable to maladjustment.

24

References
Baider, L., Ever-Hadani, P., & Kaplan De-Nour, A. (1999). Psychological distress in
healthy women with familial breast cancer: Like mother, like daughter?
International Journal of Psychiatry in Medicine, 29(4), 411-420.
Bovbjerg, D. H., & Valdimarsdottir, H. B. (2001). Interventions for healthy individuals at
familial risk for cancer. In A. Baum & B. L. Andersen (Eds.), Psychosocial
Interventions for Cancer (pp. 305-320). Washington, DC: American
Psychological Association.
Brain, K., Henderson, B. J., Tyndel, S., Bankhead, C., Watson, E., Clements, A., . . .
Group, P. S. M. (2008). Predictors of breast cancer-related distress following
mammography screening in younger women on a family history breast screening
programme. Psycho-Oncology, 17(12), 1180-1188.
Brédart, A., Kop, J. L., Fall, M., Pelissier, S., Simondi, C., Dolbeault, S., . . . Tardivon,
A. (2012). Anxiety and specific distress in women at intermediate and high risk of
breast cancer before and after surveillance by magnetic resonance imaging and
mammography versus standard mammography. Psycho-Oncology, 21(11), 11851194.
Compas, B. E., Worsham, N. L., Epping-Jordan, J. E., Grant, K. E., Mireault, G., Howell,
D. C., & Malcarne, V. L. (1994). When Mom or Dad has cancer: Markers of
psychological distress in cancer patients, spouses, and children. Health
Psychology, 13(6), 507.
den Heijer, M., Seynaeve, C., Vanheusden, K., Duivenvoorden, H. J., Bartels, C. C.,
Menke-Pluymers, M. B., & Tibben, A. (2011). Psychological distress in women at
risk for hereditary breast cancer: The role of family communication and perceived
social support. Psycho-Oncology, 20(12), 1317-1323.
den Heijer, M., Seynaeve, C., Vanheusden, K., Timman, R., Duivenvoorden, H. J.,
Tilanus-Linthorst, M., . . . Tibben, A. (2013). Long-term psychological distress in
women at risk for hereditary breast cancer adhering to regular surveillance: A risk
profile. Psycho-Oncology, 22(3), 598-604.
Erblich, J., Bovbjerg, D. H., & Valdimarsdottir, H. B. (2000). Looking forward and back:
Distress among women at familial risk for breast cancer. Annals of Behavioral
Medicine, 22(1), 53-59.
Esplen, M. J., & Hunter, J. (2002). Grief in women with a family history of breast cancer.
Primary Psychiatry, 9(5), 57-64.
Facione, N. C. (2002). Perceived risk of breast cancer. Cancer Practice, 10(5), 256-261.

25

Field, K. M., & Phillips, K. (2007). Management of women at high familial risk for
breast and ovarian cancer. Cancer Forum, 31(3), 141-149.
Gail, M. H., Brinton, L. A., Byar, D. P., Corle, D. K., Green, S. B., Schairer, C., &
Mulvihill, J. J. (1989). Projecting individualized probabilities of developing breast
cancer for white females who are being examined annually. Journal of the
National Cancer Institute, 81(24), 1879-1886.
Gilbar, O. (1998). Coping with threat. Implications for women with a family history of
breast cancer. Psychosomatics, 39(4), 329-339.
Gopie, J. P., Vasen, H. F., & Tibben, A. (2012). Surveillance for hereditary cancer: does
the benefit outweigh the psychological burden? A systematic review. [Review].
Crit Rev Oncol Hematol, 83(3), 329-340.
Hymmen, P., Stalker, C. A., & Cait, C.-A. (2013). The case for single-session therapy:
Does the empirical evidence support the increased prevalence of this service
delivery model? Journal of Mental Health, 22(1), 60-71.
Radloff, L. S. (1977). The CES-D Scale. Applied Psychological Measurement, 1(3), 385401.
Raveis, V. H., & Pretter, S. (2005). Existential plight of adult daughters following their
mother's breast cancer diagnosis. Psycho-Oncology, 14(1), 49-60.
Rijnsburger, A. J., Essink-Bot, M. L., van Dooren, S., Borsboom, G. J., Seynaeve, C.,
Bartels, C. C., . . . de Koning, H. J. (2004). Impact of screening for breast cancer
in high-risk women on health-related quality of life. British Journal of Cancer,
91(1), 69-76.
Schwartz, M. D., Isaacs, C., Graves, K. D., Poggi, E., Peshkin, B. N., Gell, C., . . . Perley,
L. (2012). Long-term outcomes of BRCA1/BRCA2 testing: Risk reduction and
surveillance. Cancer, 118(2), 510-517.
Spielberger, C. D., Gorsuch, R. L., & Lushene, R. E. (1970). Manual for the State-Trait
Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press.
Thewes, B., Meiser, B., Tucker, K., & Schnieden, V. (2003). Screening for psychological
distress and vulnerability factors in women at increased risk for breast cancer: A
review of the literature. Psychology, Health & Medicine, 8(3), 289-304.
Tyndel, S., Austoker, J., Henderson, B. J., Brain, K., Bankhead, C., Clements, A., &
Watson, E. K. (2007). What is the psychological impact of mammographic
screening on younger women with a family history of breast cancer? Findings
from a prospective cohort study by the PIMMS Management Group. Journal of
Clinical Oncology, 25(25), 3823-3830.

26

Valdimarsdottir, H. B., Bovbjerg, D. H., Kash, K. M., Holland, J. C., Osborne, M. P., &
Miller, D. G. (1995). Psychological distress in women with a familial risk of
breast cancer. Psycho-Oncology, 4(2), 133-141.
van Dooren, S., Seynaeve, C., Rijnsburger, A. J., Duivenvoorden, H. J., Essink-Bot, M.
L., Tilanus-Linthorst, M. M., . . . Tibben, A. (2005). Exploring the course of
psychological distress around two successive control visits in women at hereditary
risk of breast cancer. European Journal of Cancer, 41(10), 1416-1425.
van Oostrom, I., Meijers-Heijboer, H., Duivenvoorden, H. J., Brocker-Vriends, A. H.,
van Asperen, C. J., Sijmons, R. H., . . . Tibben, A. (2006). Experience of parental
cancer in childhood is a risk factor for psychological distress during genetic
cancer susceptibility testing. Annals of Oncology, 17(7), 1090-1095.
van Oostrom, I., Meijers-Heijboer, H., Duivenvoorden, H. J., Brocker-Vriends, A. H.,
van Asperen, C. J., Sijmons, R. H., . . . Tibben, A. (2007). Family system
characteristics and psychological adjustment to cancer susceptibility genetic
testing: A prospective study. Clinical Genetics, 71(1), 35-42.
van Oostrom, I., Meijers-Heijboer, H., Lodder, L. N., Duivenvoorden, H. J., van Gool, A.
R., Seynaeve, C., . . . Tibben, A. (2003). Long-term psychological impact of
carrying a BRCA1/2 mutation and prophylactic surgery: A 5-year follow-up
study. Journal of Clinical Oncology, 21(20), 3867-3874.
Visser, A., Huizinga, G. A., van der Graaf, W. T., Hoekstra, H. J., & Hoekstra-Weebers,
J. E. (2004). The impact of parental cancer on children and the family: A review
of the literature. Cancer Treatment Reviews, 30(8), 683-694.
Watson, E. K., Henderson, B. J., Brett, J., Bankhead, C., & Austoker, J. (2005). The
psychological impact of mammographic screening on women with a family
history of breast cancer-A systematic review. Psycho-Oncology, 14(11), 939-948.
Watson, M., James-Roberts, I., Ashley, S., Tilney, C., Brougham, B., Edwards, L., . . .
Romer, B. (2005). Factors associated with emotional and behavioural problems
among school age children of breast cancer patients. British Journal of Cancer,
94(1), 43-50.
Wellisch, D. K., Gritz, E. R., Schain, W., Wang, H. J., & Siau, J. (1991). Psychological
functioning of daughters of breast cancer patients. Part I: Daughters and
comparison subjects. Psychosomatics, 32(3), 324-336.
Wellisch, D. K., Gritz, E. R., Schain, W., Wang, H. J., & Siau, J. (1992). Psychological
functioning of daughters of breast cancer patients. Part II: Characterizing the
distressed daughter of the breast cancer patient. Psychosomatics, 33(2), 171-179.

27

Wellisch, D. K., Ormseth, S. R., Hartoonian, N., & Owen, J. E. (2012). A retrospective
study predicting psychological vulnerability in adult daughters of breast cancer
patients. Families, Systems & Health, 30(3), 253-264.
Zakowski, S. G., Valdimarsdottir, H. B., Bovbjerg, D. H., Borgen, P., Holland, J., Kash,
K., . . . Van Zee, K. (1997). Predictors of intrusive thoughts and avoidance in
women with family histories of breast cancer. Annals of Behavioral Medicine,
19(4), 362-369.

28

CHAPTER THREE
PREDICTING REATTENDANCE TO A HIGH-RISK
BREAST CANCER CLINIC

Sarah Ormseth, M.A., David Wellisch, Ph.D.,
Adam Aréchiga, Psy.D., DrPH, Taylor Draper, M.A.

Abstract
Research about follow-up patterns of women attending high-risk breast cancer
clinics is limited. The objective of this study is to profile daughters of breast cancer
patients who are likely to return versus those unlikely to return for follow-up care in a
high-risk clinic. This longitudinal investigation included 131 patients attending the
UCLA Revlon Breast Center High Risk Clinic. Predictor variables included age,
computed breast cancer risk, participants’ perceived personal risk, clinically significant
depressive symptomatology (CES-D score ≥ 16), current level of anxiety (State-Trait
Anxiety Inventory), and survival status of participants’ mothers (survived or passed away
from breast cancer). Results showed that a greater likelihood of reattendance was
associated with older age (adjusted odds ratio [AOR] = 1.07, p = .004), computed breast
cancer risk (AOR = 1.10, p = .017), absence of significant depressive symptomatology
(AOR = 0.25, p = .009), past psychiatric diagnosis (AOR = 3.14, p = .029), and maternal
loss to breast cancer (AOR = 2.59, p=.034). Also, an interaction was found between
mother’s survival status and perceived risk (p = .019), such that reattendance was
associated with higher perceived risk among participants whose mothers survived, (AOR
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= 1.04, p = .002), but not those whose mothers died (AOR = 0.99, p = .685).
Furthermore, a non-linear inverted “U” relationship was observed between state anxiety
and reattendance (p = .037); participants with moderate anxiety were more likely to
reattend than those with either low or high anxiety levels. Findings highlight the
importance of psychological factors in predicting reattendance to a high-risk breast
cancer clinic. Explication of profiles of women who may or may not follow-up offers the
possibility of intervention from the first visit to increase the likelihood of follow-up care.
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Introduction
For women at high risk for breast cancer, screening is the mainstay of risk
management. Given that evidence-based cancer screening and risk reduction strategies
for women with a family history of breast cancer are complex and dynamic, optimal risk
management is likely to be in the context of a multidisciplinary setting (Field & Phillips,
2007). The advantages of multidisciplinary high-risk care has resulted in
recommendations for, and the development of, such clinics (Kuschel, Lux, Goecke, &
Beckmann, 2000). High risk clinics provide continual surveillance, screening, and
management for high-risk women in a centralized context. Despite the benefits of
multidisciplinary high-risk cancer surveillance programs, many women with a family
history of breast cancer do not attend or re-attend for continued screening and risk
management (Hailey, Carter, & Burnett, 2000).
While extant research has identified a number of barriers and facilitators of
screening adherence among women at high risk for breast cancer, few studies have
examined factors related to re-attendance. Previous studies have primarily focused on
prior screening experiences and a limited set of demographic variables and have shown
an association between a decreased likelihood of reattendance and reluctance at initial
attendance, negative past screening experiences, prior mammography screening, a foreign
language background, and greater rurality (Bulliard, De Landtsheer, & Levi, 2003;
Cockburn, Schofield, White, Hill, & Russell, 1997; Katapodi, Lee, Facione, & Dodd,
2004; Price et al., 2010; Tatla et al., 2003). Research on reattendance is particularly
important considering that attendance rates tend to decline with successive screening
(Fink, Shapiro, & Roester, 1972; Taylor, Taplin, Urban, White, & Peacock, 1995).
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Therefore, research examining additional factors related to reattendance is essential for
increasing rates of reattendance (Cockburn et al., 1997).
Among high-risk women, some evidence suggests that elevated levels of distress
and depressive symptoms relate to decreased screening adherence (Kash, Holland,
Halper, & Miller, 1992; Price et al., 2010; Wellisch & Lindberg, 2001). While anxiety
has been found to be related with both screening avoidance and adherence (Consedine,
Magai, Krivoshekova, Ryzewicz, & Neugut, 2004; Hailey, 1991; Kash et al., 1992;
Lerman et al., 1993; Lerman, Kash, & Stefanek, 1994; Lindberg & Wellisch, 2001;
Meiser et al., 2000), there is some evidence that the anxiety-adherence relationship may
be non-linear with likelihood of adherence declining both with increasing or decreasing
levels of anxiety (Meiser et al., 2000; Zhang et al., 2012). Literature evaluating the effect
of lifetime psychiatric history on reattendance behavior is more limited. However,
consistent with the kindling hypothesis (Kendler, Karkowski, & Prescott, 1999), it might
be expected that high-risk women with a history of depression or anxiety may be
sensitized to stressful life events such as maternal illness and death and experience
subsequent maladaptation. Indeed, previous research has demonstrated an association
between past psychiatric illness and current affective difficulties among women at high
risk for breast cancer (Hopwood et al., 1998).
Studies have also examined perceived risk as a correlate of breast cancer
screening among high-risk women, though findings have been inconsistent. Perceived
risk has shown a positive association with breast cancer screening (Consedine et al.,
2004; Lerman et al., 1993; McCaul, Branstetter, O'Donnell, Jacobson, & Quinlan, 1998;
McCaul, Schroeder, & Reid, 1996; Zhang et al., 2011), and has also been shown to be
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unassociated with screening (Diefenbach, Miller, & Daly, 1999; Gorin & Albert, 2003;
Isaacs et al., 2002; Martin & Degner, 2006). However, a recent comprehensive review
about perceived risk and adherence to breast cancer screening among women with
familial breast cancer risk reported a weak to moderate positive relationship between
perceived breast cancer risk and mammography adherence (Walker et al., 2013).
Demographic characteristics also likely affect screening re-attendance. Research
indicates that older age and being married/partnered predicts screening uptake (Price et
al., 2010; Rahman, Dignan, & Shelton, 2005), as well as reattendance for breast cancer
screening (Pakenham, Pruss, & Clutton, 2000). Reattendance may also be related to
aspects of women’s experiences of breast cancer in their families. Research has shown
that women with a breast cancer death in the family were more likely to have had a recent
mammogram compared with women with only a breast cancer survivor in the family
(Tracy et al., 2008). However, the association between mothers’ survival from breast
cancer and daughters’ reattendance rates to high-risk clinics has not yet been examined.
The main aim of this study was to profile women who are likely to return versus
those unlikely to return for follow-up care in a high risk breast cancer clinic, with a
specific focus on daughters of breast cancer patients. A set of hypotheses emerge from
the literature that this study can help evaluate. It was expected that demographic
characteristics would be associated with an increased likelihood of reattendance,
including older age and being married/partnered. Next, it was hypothesized that
depressive symptomatology, lifetime psychiatric diagnoses, perceived breast cancer risk,
and survival status of the mother will be associated with likelihood of reattendance.
Specifically, an increased likelihood of reattendance was expected to be associated with
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higher levels of perceived risk and maternal loss to breast cancer, while a decreased
likelihood of reattendance was expected to be associated with clinically significant
depressive symptoms and having a previous diagnosis of a psychiatric disorder. It was
also hypothesized that the relationship between state anxiety and reattendance will be
curvilinear in nature such that reattendance will be more strongly associated with
moderate levels of anxiety than milder anxiety or more severe anxiety. Finally, it was
hypothesized that survival status of the mother will moderate the effects of the
aforementioned hypothesized predictors on likelihood of reattendance.

Method
The data for the present study were obtained during the patients’ first three
appointments at the UCLA Revlon Breast Center High Risk Clinic. The High Risk Clinic
is a multidisciplinary center that setting that serves patients at familial risk for breast
cancer. During their initial visit to the clinic, patients are individually seen and counseled
by an oncologist, a genetics counselor, a nurse practitioner, a nutritionist, and a
psychologist; most patients also receive a mammogram. During follow-up visits, patients
are seen by specific members of the team according to the patient’s needs.
Institutional Review Board approval was granted prior to data collection. Women
were eligible for participation if their biological mother had been diagnosed with breast
cancer, were at least 18 years old, were English-speaking, and had never themselves been
diagnosed with breast cancer. Data for 131 patients from the High Risk Clinic from were
available for analyses for the current study. A psychologist conducted a semi-structured
clinical interview with participants during their first appointment, in which psychosocial
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background information was obtained. Participants also completed questionnaires
assessing depression and anxiety symptoms during their initial appointment.

Measures
The primary outcome variable was reattendance to the high-risk clinic, defined as
a dichotomous measure of whether patients returned for a follow-up appointment
(reattendance coded as 1, did not follow-up as 0).
To ascertain their mothers’ survival from breast cancer, participants were asked
whether their mothers were still alive, and cause of death if deceased (died from breast
cancer coded as 1, alive or non-breast cancer death as 0). Perceived risk was assessed by
having participants rate from 0 (not at all likely) to 100 (extremely likely) the likelihood
that they would ever develop breast cancer. Participants were also asked about their
lifetime history of any diagnosed psychiatric condition (previous psychiatric diagnosis
coded as 1, no psychiatric history as 0).
The State-Trait Anxiety Inventory (STAI; (Spielberger, Gorsuch, & Lushene,
1970) was used to evaluate current level of anxiety (“state anxiety”). The State scale
contains 20 items and responses are measured on a 4-point Likert scale, with higher
scores signifying the presence of higher levels of anxiety. The STAI manual reports high
internal consistency State scale (α = .92), which was replicated in this study (α = .90).
The Center for Epidemiologic Studies Depression Scale (CES-D;(Radloff, 1977)
was used to assess current depressive symptomatology. The CES-D consists of 20 items
and scores may range from of 0 to 60, with higher scores signifying the presence of more
symptomatology. The test has good reliability (α = .85 for general population; α = .90 for
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clinical population); the reliability of the scale was strong in the current study (α = .95).
Although not constituting a clinical diagnosis of depression, scores at or above 16 on the
CES-D are considered indicative of clinically significant symptoms of depression.
Additionally, a number of variables were considered as potential covariates
including age in years at interview, ethnicity (Caucasian or non-Caucasian), marital status
(married/partnered or never married/partnered), educational attainment (high school,
some college, college graduate, or graduate school), employment status (currently
employed or unemployed), participant age at the time of mother’s breast cancer
diagnosis, mother’s age at the time of diagnosis, number of relatives with a past or
present breast cancer diagnosis, and computed breast cancer risk using the Gail model
(Gail et al., 1989).

Statistical Analyses
Analyses were conducted using SPSS 19.0. Associations between reattendance
and potential control variables were examined using χ2 and t tests for categorical and
continuous variables, respectively. Variables that had a significant association
reattendance were included as covariates in the multivariate models to ascertain unbiased
point estimates. Three multivariate logistic regression models were used to predict
reattendance as a dependent variable, with results expressed in adjusted odds ratio
(AORs) with 95% confidence intervals (CIs). The first model assessed likelihood of
reattendance based on the focal main effects, after controlling for relevant covariates.
Perceived breast cancer risk, depressive symptomatology, state anxiety percentile score,
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personal history of a psychiatric diagnosis, and survival status of participants’ mothers
were included in the model as main effects.
Next, to test the moderating effects of mother’s survival status, the two-way
interactions of survival status with perceived risk and the other focal predictors were
considered. Continuous predictors were mean centered prior to creating interaction terms
(Aiken & West, 1991). Preliminary analyses revealed three non-significant interaction
terms (survival × state anxiety, survival × depression, and survival × past
psychopathology, Fs < 1). Thus, these terms were trimmed, and the significance of the
survival status × perceived risk interaction effect was tested in the multivariate model. In
may be non-linear. Quadratic anxiety scores were computed by squaring the centered
state anxiety scores. Likelihood ratio tests were used to determine whether the increment
in the proportion of variance accounted for by addition of the higher-order terms was
statistically significant. Statistically significant interaction and quadratic effects were
depicted graphically using locally weighted scatterplot smoothing (Lowess) to facilitate
the visual interpretation of the plots (Cleveland, 1979).

Results
A total of 131 (65 reattended; 66 did not return) participants were included in the
study. Table 5 shows background characteristics of the sample. With respect to age, the
overall sample was relatively young (M = 39.85, SD = 10.10) and exhibited absolute
breast cancer risks moderately higher than that in the general population (18.24 percent
calculated lifetime risk). Additionally, the majority of participants were Caucasian
(81.68%, n = 107), married (61.07%, n = 80), and had a college or advanced degree
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Table 5
Demographic characteristics of participants who returned for a follow-up
appointment compared to those who did not
Total Sample
(N = 131)

Variable

M ± SD or n (%)
Age in years*

39.85 ± 10.10

Attended Follow-up Appointment
Yes (n = 65)
No (n = 66)
M ± SD or n (%)
42.75 ± 9.23

M ± SD or n (%)
36.99 ± 10.17

Marital status*
Married or partnered

82 (62.60)

50 (76.92)

32 (48.49)

Not married or partnered

49 (47.40)

15 (23.08)

34 (51.51)

107 (81.68)

54 (83.08)

53 (80.30)

Non-Caucasian
Education

24 (18.32)

11 (16.92)

13 (19.70)

High school

8 (6.11)

3 (4.62)

5 (7.58)

Some college

18 (13.74)

12 (18.46)

6 (9.10)

College graduate

48 (36.64)

21 (32.31)

27 (40.91)

Graduate school

57 (43.51)

29 (44.62)

28 (42.42)

Employment status
Unemployed

30 (22.90)

13 (20.00)

17 (25.76)

101 (77.10)

52 (80.00)

49 (74.24)

Ethnicity
Caucasian

Employed
Computed breast cancer risk*

18.24 ± 7.15

19.62 ± 9.20

16.87 ± 3.88

Number of relatives with BC

2.12 ±1.21

2.15 ± 1.29

2.08 ± 1.27

Age at mother’s diagnosis

24.18 ± 11.80

24.98 ±11.69

23.40 ± 11.94

Mother’s age at diagnosis

51.35 ± 11.94

50.32 ±12.87

52.40 ±10.90

*p < .05 for differences between participants who did and did not reattend.

(80.15%, n = 105). The background characteristics of these two groups were generally
similar. However, compared to participants who returned for a follow-up appointment,
participants who did not reattend were younger (t(129) = -3.40, p = .001), less likely to be
married (χ2(1)=11.31, p = .001) and had a lower computed breast cancer risk (t(129) = 2.22, p = .029). Given these findings, age, marital status and computed breast cancer risk
were used as control variables.
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The main effects model discriminated well between patients who did and did not
return for follow-up, 2(8) = 45.89, p < .001, and accounted for 39.4% of the variance in
reattendance (Nagelkerke R2 = 0.39). The coefficients for seven of the eight hypothesized
predictors were statistically significant (p < .05). Odds ratios for the independent
variables are presented in Table 6. When holding other variables constant, this model
suggests that likelihood of reattendance increased by eight percent for each one year
increase in age, and each one standardized unit increment in computed breast cancer risk
was associated with an 11 percent rise in likelihood of reattendance. For each one
standardized unit increment in perceived breast cancer risk, likelihood of reattendance
increased by two percent. Participants with clinically significant distress were only about
21 percent as likely to reattend as those did not demonstrate marked depressive

Table 6
Sample characteristics and multivariate logistic regression predicting reattendance
Attended Follow-up Appointment
Variable

Yes (n = 65)

No (n = 66)

M ± SD or n (%)

M ± SD or n (%)

Multivaraite
Logistic Regression
AOR (95% CI)

p

Age in years

42.75 ± 9.23

36.99 ± 10.17

1.07 (1.02–1.13) .004

Computed breast cancer risk

19.62 ± 9.20

16.87 ± 3.88

1.10 (1.02–1.20) .017

Married or partnered

50 (76.92)

32 (48.49)

1.98 (0.80–4.88) .141

Significant distress (CES-D)

12 (18.46)

23 (34.85)

0.25 (0.09–0.71) .009

Prior psychiatric diagnosis

22 (33.85)

14 (21.21)

3.14 (1.13–8.74) .029

State Anxiety percentile

64.24 ± 7.70

66.08 ± 9.50

0.95 (0.90–1.00) .049

Perceived breast cancer risk

56.77 ± 24.81

48.27 ± 24.99

1.02 (1.00–1.04) .035

Maternal breast cancer loss

35 (53.85)

23 (34.85)

2.59 (1.08–6.23) .034
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symptomatology. For each one percentile increase in state anxiety, likelihood of
reattendance decreased by five percent. Finally, the likelihood of reattendance among
participants who reported a past psychiatric diagnosis was over three times as large as
those without a psychiatric history, and the likelihood of reattendance among participants
whose mothers died from breast cancer was almost three times that of participants whose
mothers survived breast cancer.
In addition to main effects, the interaction of survival status and perceived risk
was also assessed. While the significance of all other previously present predictors
remained virtually unchanged, entry of this interaction term into the multivariate model
significantly improved the fit over the main effects only model, χ2inc(1) = 5.53, p = .019,
Nagelkerke R2 = 0.43. This suggests that the association between perceived risk and
likelihood of reattendance was moderated by mother’s survival status. To facilitate
interpretation of this significant interaction effect, the association between perceived risk
and likelihood of reattendance was examined separately among daughters whose mothers
died from breast cancer and daughters whose mothers survived (see Figure 4). Analyses
revealed that higher perceived risk was associated with a greater likelihood of
reattendance among participants whose mothers survived breast cancer (p = .002, AOR =
1.04, 95% CI: 1.01–1.07). In contrast, no association was shown between perceived risk
and reattendance among participants whose mothers died (p = .685, AOR = 0.99, 95%
CI: 0.97–1.02). This interaction effect is illustrated in Figure 4, which shows predicted
probabilities of reattendance based on perceived breast cancer risk, stratified by mother’s
survival status.
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Figure 4. Predicted probability of reattendance as function of perceived breast cancer
risk for daughters whose mothers survived and died from breast cancer (plotted using
Lowess smoothing with bandwidth 0.8).

To assess nonlinearity in the association between state anxiety and likelihood of
reattendance, a quadratic effect for state anxiety term was introduced to the multivariate
logistic regression model. As previously discussed, the linear state anxiety term was
significantly associated with reattendance in the main effects model (see Table 6). When
the quadratic term was entered into the model, all previously significant main effects
remained as such, including the linear state anxiety term (p = .049, AOR = 0.95, 95% CI:
0.90–0.99). The quadratic state anxiety term was also shown to be significant (p = .037,
AOR = .99, 95% CI: 0.99–1.00), and the addition of this term resulted in a significant
model improvement, χ2inc(1) = 6.26, p = .012, Nagelkerke R2 = 0.44, demonstrating that a
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Figure 5. Estimated predicted probability of reattendance as function of state anxiety
percentile scores (plotted using Lowess smoothing with bandwidth 0.8).

nonlinear relationship better described the data. A figure examining the association
between state anxiety and likelihood of reattendance plotted the predicted probability of
reattendance as a function of state anxiety. As shown in Figure 5, the peak probability of
reattendance implied by the model occurs at a state anxiety percentile of about 60, with
reattendance declining both with increasing or decreasing levels of state anxiety.

Discussion
As predicted, demographic characteristics were found to be related to clinic
attendance. Specifically, our hypothesis that increased age and being married/partnered
would be associated with reattendance was in fact borne out by the data. Though not
significant in in multivariate analyses, the finding that greater reattendance was observed
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among participants who were married/partnered supports the results of previous studies
(Pakenham et al., 2000). Some suggest that a stable relationship provides the social
support that is often related to higher levels of adherence with health recommendations
(Lerman, Rimer, Trock, Balshem, & Engstrom, 1990). Age was significant in the
multivariate model and, holding all other variables constant, it was found that each year
of increased age was associated with a seven percent greater likelihood of reattendance;
likelihood of reattendance doubled with each decade of age. This agrees with the thrust of
the literature that older age is predictive of greater reattendance as well as adherence to
breast cancer screening practices such as mammography (Pakenham et al., 2000; Price et
al., 2010; Rahman et al., 2005). We view this as logical because older patients would
have more stability and security in their lives personified by long-term committed
relationships, having children, and more established career patterns. These life issues help
support such older patients in facing the anxiety of high risk status and clinic attendance,
and offer more reason to live, thus reinforcing the possibility of clinic reattendance. We
have often been told by patients in the clinic that a key reason for them to keep
reattending is to identify any possible breast cancer early to allow them to be there for
their children and grandchildren.
Clinically significant depressive symptoms turned out to be among the most
significant predictors of non-reattendance to the clinic. Our hypothesis was supported in
that those patients with clinically significant depressive symptomatology (CES-D score
of 16 or higher) were only 25 percent as likely to return for follow-up. In our view,
reattendance to the clinic requires motivation, energy, cognitive organization, emotional
resilience and other factors that are depleted by the existence of significant depressive

43

symptomatology. This begins to make a case for measuring depression at baseline in
clinics such as this, and with patients found to have CES-D scores above 16, to be given
additional attention. This might be characterized by offering them more emotional
support, time with a clinic mental health professional in the first visit, and more diligent
call backs to ensure that patients schedule and attend follow-up appointments.
Additionally, efforts can be made to link them up with outside mental health systems to
so as not to take a wait and see approach but to take action on day one given such a
clinical finding.
For patients with a CES-D score of 16 or greater, clinicians may consider
reviewing the endorsed items with the patient in the first consultation session. For
example, if a patient is endorsing significant sleep difficulties, we recommend attempting
to understand what is occurring, why this is occurring, and discussing with the patient
about pragmatic interventions and even strategies she can take home from the first clinic
consultation visit. We view this kind of collaborative problem solving as useful in
creating a bond with the patient and helping to instill hope that her concerns will be heard
and addressed, thus leading to increased motivation to return for future visits.
With regard to our hypothesis about a previous diagnosis of a psychiatric
condition, we appear to have been dramatically mistaken in our prediction. Unexpectedly,
a history of a psychiatric diagnosis proved to be predictive of substantially greater
likelihood of clinic reattendance. The data showed that having one or more previous
psychiatric diagnoses increased likelihood of clinic reattendance by a factor of three. This
is in sharp contrast to the finding that current clinically significant symptoms of
depression eventuated in significantly less likelihood of reattendance. However, it is
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important to note that having a previous psychiatric diagnosis does not equate necessarily
to having a current psychiatric diagnosis. Moreover, the presence of anxiety and
significant depressive symptomatology were statistically controlled for in consideration
of the effects of this variable. It is possible that having had a previous diagnosis sensitizes
one to the value and need for clinical care, and that such patients are likely to be more
motivated and more accepting of clinical care in a situation such as the high risk clinic.
This is not to imply that we take these past diagnoses lightly, but view them as being a
potential positive prognostic factor in the formation of the treatment alliance with the
clinic. These findings suggest that such history should not be considered as a rule out
factor that would preclude continuity of care, but perhaps as an asset and motivating
factor in continuity of care.
The hypothesis that maternal loss to breast cancer would predict higher likelihood
of compliance with clinic attendance was basically borne out in the data analysis. This
finding is consistent with existing research showing that loss of a close family member to
breast cancer may motivate reattendance and adherence to cancer screening
recommendations (Tracy et al., 2008). By itself, it is a powerful predictor with results
indicating that participants who lost their mothers to breast cancer were over 2.5 times
more likely to attend a follow-up appointment. However, and as posited in the final
hypothesis, the data in this study reflect the fact that this variable cannot be considered in
isolation but should be considered in an interactional context with other relevant
predictors.
We considered this variable in relation to perceived risk and in doing so
discovered that perceived risk differentially impacts on reattendance according to
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maternal loss. Results demonstrated that mother’s survival status moderated the
relationship between reattendance and perceived risk such that a higher level of perceived
risk was associated with a greater likelihood of reattendance only for participants whose
mothers survived breast cancer. This finding has sensitized us to be more attentive to
patients whose mothers survived who perceive themselves at lower risk. The data show
that these daughters are significantly less likely to return, even though their actual risk
may be higher than they perceive. For the women whose mothers died from breast
cancer, perceived risk become somewhat of a moot point in predicting clinic return. They
are more likely to reattend regardless of level of perceived risk. It appears that the fact
their mothers died from breast cancer is decisive in their patterns of reattendance.
With regard to the hypothesis that the association between anxiety and
reattendance will be curvilinear, this was robustly supported by the data. It was clearly
shown that when anxiety reaches a clinically elevated level, it profoundly affects the
likelihood of clinic reattendance. Previous literature has shown anxiety to negatively
affect breast cancer surveillance (Kash et al., 1992). However, we felt it was necessary to
examine the role of anxiety in a curvilinear fashion in regard to the complexity of issues
of reattendance. It is evident, in our data, that a certain level of anxiety is motivating and
facilitative of clinic attendance and reattendance. There is literature which shows that the
effects of anxiety on adherence to recommended screening practices is best considered as
an inverted “U” (Zhang et al., 2012).
Similar to the data we found and discussed earlier on depressive symptoms, this
data on state anxiety symptoms has sensitized us to the need to carefully identify and
consider immediate intervention with the patient showing significant clinical anxiety on a
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screening measure such as the State Trait Anxiety Inventory. At the middle part of the
anxiety curve, we have learned to perceive anxiety as a motivating and facilitating feature
in regard to clinic reattendance. Too little anxiety and too much anxiety appear to place
patients at an increased risk for non-reattendance. Therefore, in addition to identifying
patients who are overwhelmed with anxiety, we have learned to be equally concerned
with identification of patients with seemingly too little anxiety appropriate to the context
of our clinical situation. It may be that patients endorsing minimal levels of anxiety are
utilizing the defense mechanisms of denial, suppression, or repression in ways that do not
facilitate the optimal adherence with their clinical care. With regard to the patients with
clearly identifiable severe anxiety, we see the necessity of extra and intensive
interventions starting from the point of the initial visit. Anxiety may be related to posttraumatic stress disorder which has been previously identified in women at high risk who
have witnessed fatal breast cancer in their mother or other close family relatives
(Lindberg & Wellisch, 2001). It is essential that such patients be offered anxiety
management interventions starting from the baseline visit to the clinic. This may be
particularly necessary in helping such patients deal with issues such as breast selfexamination, mammography, and integration of risk information (Kash et al., 1992).
It is important to take some limitations into consideration when interpreting the
findings from the present study. The demographics of the study sample were weighted
toward Caucasian, highly educated, married women, thus limiting generalizability to
other populations. Additionally, it cannot be assumed that the subset of patients who did
not return to the high risk clinic did not get other types of surveillance in another clinical
setting. In future studies, the assessment of depression, anxiety, and past psychiatric
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history should be strengthened through use of the Structured Clinical Interview for the
Diagnostic Statistical Manual modules for Major Depressive Disorder, Generalized
Anxiety Disorder, and Post-Traumatic Stress Disorder, at a minimum, as well as a more
detailed questionnaire regarding general past psychiatric history.
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CHAPTER FOUR
CONCLUSION

The emergence of multidisciplinary high risk clinics offer significant promise for
women with a familial risk for breast cancer. Familial risk is especially high for women
with first-degree relatives, such as those with mothers diagnosed with breast cancer
(Calle et al., 1993; Sattin et al., 1985; Sellers et al., 1999; Slattery & Kerber, 1993). High
risk clinics provide continual surveillance, screening, and management for these women
using a multidisciplinary approach that integrates services from oncologists, nurse
practitioners, nutritionists, clinical psychologists, and genetics counselors according to
the patient’s needs (Antill et al., 2005). Regular screening (mammography, MRI, CBE,
ultrasound, and BSE), as well as integrated services are useful in detecting breast cancer
in women with a familial risk of breast cancer (Chart & Franssen, 1997; Kuhl et al.,
2010; Larsson et al., 1996; Tabar et al., 1985). Although believed to provide benefit,
extant research has not established the psychological effects of attending regular
surveillance appointments. Additionally, existing research has not shed light on why
some high-risk women do not return for even a second visit in spite of the significant
upside of adhering to regular surveillance.
One of the more significant appreciations to be gained from this research is that
while some similarities may be shared, as a population, women at high risk for breast
cancer are enormously complex. This was evident among a group of women limited to
daughters of breast cancer patients, a study sample some might be considered as less
heterogeneous in nature. An approach that proved useful in this research may also be
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useful in future studies in efforts to disentangle the complexities that will likely be
encountered. In particular, insight afforded by the results of these studies is the value and
need to consider moderating variables when examining predictors of a phenomena. Much
of the previous literature in this area, examining reattendance as well as adjustment
among high-risk women, has not yielded robust results. It might be the case that from the
same data that originally provided finding best described as equivocal, if it were
reanalyzed with consideration of moderating factors, perhaps the results would be
something theoretically and clinically meaningful. In both studies, mother’s survival
status was modeled in interaction terms with other predictors, and this alone led to
interesting and useful results. This dataset, and most others as well, likely have not yet
been fully potentiated and a small bit of additional work and creative thinking to identify
potential moderators could lead to remarkable findings.
Taken together, the findings from these studies also underscore the need for
clinicians to attend to those patients who we would not expect to be distressed, and even
those who deny feeling distress whatsoever. For example, as discussed in Chapter 2,
despite what “reasonable” expectations may dictate, it is sometimes the case that
daughters whose mothers survived experience greater distress. In Chapter 3, the
curvilinear relationship between anxiety and reattendance showed high levels of distress
to be associated with a decreased likelihood of reattendance. Given the effectiveness of
surveillance programs are contingent on continued attendance, this is concerning, and
points towards the usefulness of screening measures to identify patients in immediate
psychological need. While patients reporting elevated levels of anxiety are a matter of
concern for physicians and psychologists alike, the quadratic, inverted “U” pattern of the
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association between anxiety and reattendance also helps to bring attention to another
subgroup of at risk women represented on the opposite side of the graph who should be
of equal if not perhaps greater concern.
These patients are in some ways at greater risk because they do not demonstrate
distress or convey a need for support that oftentimes catches the attention of mental
health clinicians. To block or deny anxiety in a setting where at least moderate feelings of
anxiety are normative is troubling but a challenge to deal with because these patients will
not be as receptive to offers of support. Because women endorsing very minimal anxiety
appear at risk for not returning for follow-up, support in the form of a phone call from the
office staff to schedule timely follow-ups or provide reminders of upcoming
appointments may is a good starting place. Another underserved but at risk patient group
highlighted by this research is the half of women not returning for a follow-up visit at the
high-risk clinic. It is unfortunate that many of these women, who appear to be
experiencing significant distress, perhaps to a greater degree than patients who reattend,
are also those least accessible to mental health clinicians by virtue of their absence.
Beyond empirical, academic and theoretical contributions, an equally if not more
important contribution of these studies is to resensitize clinicians and health professionals
to the reality that the patients most in need of support and healing oftentimes are those
who do not voice their distress or appear to be experiencing difficulty. As with the half of
the sample of high-risk women who did not reattend, there are opportunities to identify
and offer support to the distressed who are less visible, and even just having a renewed
appreciation of the potential need of such patients will allow to be better clinicians to
more of the patients who really need us.
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